A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma

Immune-mediated adverse events are commonly seen with immune checkpoint inhibitors like nivolumab. Oncology specialists usually have to screen patients for risk factors for autoimmune diseases, since immune checkpoint inhibitors can potentially exacerbate these events. Some of the immune-mediated si...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullangi, Sanjana, Ponnam, Sreeja, Lekkala, Manidhar Reddy, Koya, Supriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288591/
https://www.ncbi.nlm.nih.gov/pubmed/34290912
http://dx.doi.org/10.7759/cureus.15703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288591/
https://www.ncbi.nlm.nih.gov/pubmed/34290912
http://dx.doi.org/10.7759/cureus.15703

Ejemplares similares